Asthma flare-ups spike in the weeks after school starts, when viral exposure, allergens, and missed maintenance treatment can ...
Allergies affect millions of Americans each year, causing symptoms like sneezing, congestion, itchy eyes, fatigue, and even asthma flare ups. For many patients, over-the-counter medications or nasal ...
Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...
The flu season has passed, but here's some important news for parents to arm themselves with before next fall. A new study published in Pediatrics on June 4 said a flu shot is key for children with ...
Your immune system is already working harder than it should Chronic inflammation is the baseline state in both diabetes and ...
THURSDAY, Oct. 23, 2025 (HealthDay News) — You may have seen recent news stories reporting that a national data investigation found that routine childhood vaccination is slipping across much of the ...
The latest advances in asthma care combine revolutionary biologics, individualized immunotherapy, and targeted treatments that address specific triggers, ditching the “one-size-fits-all” approach. The ...
GREENWICH, Conn.--(BUSINESS WIRE)--An analysis from Cedar Gate Technologies (Cedar Gate) reveals that only 34.7% of commercially insured patients diagnosed with chronic obstructive pulmonary disease ...
OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...
Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored inhaler (or "puffer"). This kind of "rescue inhaler" brings quick relief from ...
Asthma is conventionally viewed as “treatable but incurable”. In other words, we can manage its symptoms but not reverse the underlying condition. But advances in science are challenging this view and ...